750 related articles for article (PubMed ID: 26964016)
1. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
Wang G; He D; Li X; Li J; Peng Z
Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors.
Wang G; Peng Z; Gong Z; Li Y
Bioorg Chem; 2018 Aug; 78():195-200. PubMed ID: 29587132
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
[TBL] [Abstract][Full Text] [Related]
6. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors.
Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA
Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases.
Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F; Rehman AU
Bioorg Chem; 2015 Dec; 63():36-44. PubMed ID: 26432614
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro α-glucosidase inhibitory activity and molecular docking studies of new thiazole derivatives.
Khan KM; Qurban S; Salar U; Taha M; Hussain S; Perveen S; Hameed A; Ismail NH; Riaz M; Wadood A
Bioorg Chem; 2016 Oct; 68():245-58. PubMed ID: 27592296
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as α-glucosidase inhibitors.
Wang G; Chen M; Wang J; Peng Y; Li L; Xie Z; Deng B; Chen S; Li W
Bioorg Med Chem Lett; 2017 Jul; 27(13):2957-2961. PubMed ID: 28506754
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
11. Syntheses of new 3-thiazolyl coumarin derivatives, in vitro α-glucosidase inhibitory activity, and molecular modeling studies.
Salar U; Taha M; Khan KM; Ismail NH; Imran S; Perveen S; Gul S; Wadood A
Eur J Med Chem; 2016 Oct; 122():196-204. PubMed ID: 27371923
[TBL] [Abstract][Full Text] [Related]
12. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, and In Vitro and In Silico α-Glucosidase Inhibitory Studies of 5-Chloro-2-Aryl Benzo[d]thiazoles.
Shah S; Arshia ; Javaid K; Zafar H; Mohammed Khan K; Khalil R; Ul-Haq Z; Perveen S; Iqbal Choudhary M
Bioorg Chem; 2018 Aug; 78():269-279. PubMed ID: 29614438
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of α-glucosidase.
Rahim F; Ullah H; Javid MT; Wadood A; Taha M; Ashraf M; Shaukat A; Junaid M; Hussain S; Rehman W; Mehmood R; Sajid M; Khan MN; Khan KM
Bioorg Chem; 2015 Oct; 62():15-21. PubMed ID: 26162519
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P
Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li X; Li J
Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
Wang G; Chen M; Qiu J; Xie Z; Cao A
Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Isatin-Thiazole Derivatives as α-Glucosidase Inhibitors.
Xie Z; Wang G; Wang J; Chen M; Peng Y; Li L; Deng B; Chen S; Li W
Molecules; 2017 Apr; 22(4):. PubMed ID: 28425975
[TBL] [Abstract][Full Text] [Related]
20. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
